Related Experiment Video
Updated: Jul 26, 2025
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Shewanella putrefaciens: A Critically Emerging Pathogen of Ventilator-Associated Pneumonia
1Medical School, College of Osteopathic Medicine, Sam Houston State University, Houston, USA.
Abstract:
Shewanella putrefaciens is a critically emerging cause of ventilator-associated pneumonia (VAP). S. putrefaciens is an oxidase-positive, nonfermenting, hydrogen-sulfide-producing, gram-negative bacillus. Worldwide, there have been six reported cases of pneumonia and two reported cases of VAP, both caused by S. putrefaciens. In this study, we discuss the case of a 59-year-old male who presented to the emergency department with altered mental status and acute respiratory distress. He was intubated for airway protection. Eight days following intubation, the patient developed symptoms consistent with VAP, and bronchoalveolar lavage (BAL) revealed S. putrefaciens, an emerging nosocomial and opportunistic pathogen, as the causative agent. The patient was treated with cefepime with the resolution of symptoms.
More Related Videos
Related Concept Videos
01:29Pneumonia II: Pathophysiology
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:30Pneumonia III: Complications and Assessment
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.